Business and Finance

New identity stresses ‘human data science’

Revised deal brings 1,932 stores to Walgreens Boots Alliance

Bloomington, IN, facility is the prize

‘An unaffordable drug is 100 percent ineffective’

First gene therapy product in US; approval expedited by evidence of high cure rates

Investors hope for a repeat of Gilead’s Sovaldi success

Observers are critical of the $465-million penalty as too lenient

Leading CRO looks to better trial recruitment, outcomes research

A protest against not protesting; unclear consequences for pharma’s place on the White House council

New location, following Brexit, will be decided in November

GPO for academic medical centers and other providers

Cambridge BioMarketing brings orphan-drug expertise, and Vynamic brings branding and launch services

Assn. for Accessible Medicines files a federal suit against the state

Fourth annual meeting will occur Oct. 16-17

$325-million cancellation fee to be paid to Rite Aid

Specialty pharmacy accreditation attracts growing number of pharmacies

Lifetime Achievement Award goes to Michael McBride, Upsher-Smith Labs

Novartis, Pfizer and Roche will run neck-and-neck for global leader spot

The southern California region carves out a special place for genomics within biotechnology

Healthcare stakeholders ruminate on the effects of MACRA’s alternative payment models

Survey of the global business consulting market finds double-digit growth for pharma

Taking on the breadth of challenges in contract development and manufacturing, globally

Deal brings a leading CDMO under Thermo Fisher’s expansive life-sciences wings

Combined company will have revenues of $3.2 billion and a market cap of $7.4 billion

Trade association is now big companies with big R&D spending

Takes reins with prior experience at both FDA and HHS

Latest QuintilesIMS report sees 5.8% growth in 2016; more emphasis on ‘net-price’ spending

EMD Serono Specialty Digest finds they struggle over 'ensuring clinically appropriate use'